ArticleiScience2026
Pentachlorophenol enhances bladder cancer cell invasion through altered protein stability.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pentachlorophenol (PCP) is a persistent environmental contaminant, but its effect on bladder cancer invasiveness is unclear. Here, we show that environmentally relevant PCP concentrations enhance invasion of T24 and SW780 bladder cancer cells, with limited effects on migration or proliferation. Integrative target prediction, transcriptomics, and machine learning identified EGFR, MAP2K1, and NFE2L2 as candidate contributors. PCP altered the protein stability of these factors, and EGFR or MAP2K1 knockdown or NFE2L2 overexpression partially attenuated PCP-induced invasion. A three-gene signature based on these factors was associated with poor prognosis across five bladder cancer cohorts, although these datasets lacked PCP exposure information. Molecular docking and molecular dynamics simulations predicted compatible interactions between PCP and the three proteins. Together, these findings identify candidate molecular contributors to PCP-associated bladder cancer invasion and support further chronic-exposure and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.